Cancer research delves deep into the intricate interplay of genetics and epigenetics, unraveling the molecular mysteries driving cancer initiation and progression. Genetic mutations, whether inherited or acquired, disrupt the delicate balance of cell growth regulation, fueling tumorigenesis. Meanwhile, epigenetic modifications, like DNA methylation and histone alterations, can covertly switch genes on or off, orchestrating a cellular landscape conducive to cancer development. Understanding these dynamic processes not only sheds light on cancer etiology but also offers tantalizing prospects for targeted therapies and precision medicine interventions. By deciphering the genetic and epigenetic signatures underlying different cancers, researchers are forging new frontiers in diagnosis, prognosis, and personalized treatment strategies, ultimately striving towards more effective cancer management.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States